Advertisement

Picture Berlin Partner Hotspot for Startups 650x80px
Organisation › Details

Swixx Biopharma AG

Swixx operates fully owned subsidiaries across Central and Eastern Europe, Greece, and Russia. With 600 employees and sales exceeding €260 million in 2021, Swixx has swiftly evolved into the largest and fastest-growing dedicated commercialization platform for biopharma and self-medication innovative companies in CEE. The company has gathered outstanding rare disease, oncology-haematology, specialty, and self-medication talent under one roof. *

 

Period Start 2014-12-01 established
  Group Swixx Biopharma (Group)
  Today Swixx Biopharma (Group)
  Predecessor PharmaSwiss (Group)
Product Industry pharmaceutical
     
Region Region Baar ZG
  Country Switzerland
  Street 5A Neuhofstr.
  City 6340 Baar ZG
    Address record changed: 2021-05-28
     
Basic data Employees n. a.
     
    * Document for �About Section�: Swixx Biopharma AG. (5/20/21). "Press Release: Swixx Welcomes Mérieux Equity Partners as Minority Shareholder and Announces €45 Million Capital Increase". Baar.
     
   
Record changed: 2021-05-28

Advertisement

Picture [iito] Made Without Love 650x80px

More documents for Swixx Biopharma (Group)


To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Advertisement

Picture Demy-Colton BioFuture 2021 NYC B Preview Download 650x300px




» top